Fruijtier-Pölloth Claudia
CATS Consultants GmbH, Toxicology and Preclinical Affairs, Saarburgstr. 31, D-82166 Gräfelfing, Germany.
Toxicology. 2005 Oct 15;214(1-2):1-38. doi: 10.1016/j.tox.2005.06.001.
This assessment focusses on polyethylene glycols (PEGs) and on anionic or nonionic PEG derivatives, which are currently used in cosmetics in Europe. These compounds are used in a great variety of cosmetic applications because of their solubility and viscosity properties, and because of their low toxicity. The PEGs, their ethers, and their fatty acid esters produce little or no ocular or dermal irritation and have extremely low acute and chronic toxicities. They do not readily penetrate intact skin, and in view of the wide use of preparations containing PEG and PEG derivatives, only few case reports on sensitisation reactions have been published, mainly involving patients with exposure to PEGs in medicines or following exposure to injured or chronically inflamed skin. On healthy skin, the sensitising potential of these compounds appears to be negligible. For some representative substances of this class, information was available on reproductive and developmental toxicity, on genotoxicty and carcinogenic properties. Taking into consideration all available information from related compounds, as well as the mode and mechanism of action, no safety concern with regard to these endpoints could be identified. Based on the available data it is therefore concluded that PEGs of a wide molecular weight range (200 to over 10,000), their ethers (laureths. ceteths, ceteareths, steareths, and oleths), and fatty acid esters (laurates, dilaurates, stearates, distearates) are safe for use in cosmetics. Limited data were available for PEG sorbitan/sorbitol fatty acid esters, PEG sorbitan beeswax and PEG soy sterols. Taking into account all the information available for closely related compounds, it can be assumed that these compounds as presently used in cosmetic preparations will not present a risk for human health. PEG castor oils and PEG hydrogenated castor oils have caused anaphylactic reactions when used in intravenous medicinal products. Their topical use in cosmetics is, however, considered safe as they are not expected to be systemically available. As all PEGs and PEG derivatives, they must not be applied to damaged skin. Manufacturers of PEGs and PEG derivatives must continue their efforts to remove impurities and by-products such as ethylene oxide and 1,4-dioxane. Overall, it is concluded, that the PEGs covered in this review are safe for use in cosmetics under the present conditions of intended use.
本评估聚焦于聚乙二醇(PEGs)以及阴离子或非离子型PEG衍生物,这些物质目前在欧洲用于化妆品中。由于其溶解性、粘度特性以及低毒性,这些化合物被广泛应用于各种化妆品中。PEGs及其醚类和脂肪酸酯几乎不会产生眼部或皮肤刺激,且急性和慢性毒性极低。它们不易穿透完整皮肤,鉴于含PEG和PEG衍生物制剂的广泛使用,仅有少数关于过敏反应的病例报告发表,主要涉及接触药品中PEGs的患者或接触受损或慢性炎症皮肤后的患者。在健康皮肤上,这些化合物的致敏潜力似乎可以忽略不计。对于此类的一些代表性物质,可获取有关生殖和发育毒性、遗传毒性和致癌特性的信息。考虑到来自相关化合物的所有可用信息以及作用方式和机制,未发现这些终点存在安全问题。因此,根据现有数据得出结论,分子量范围广泛(200至超过10,000)的PEGs、其醚类(月桂醇聚醚、鲸蜡醇聚醚、鲸蜡硬脂醇聚醚、硬脂醇聚醚和油醇聚醚)以及脂肪酸酯(月桂酸酯、二月桂酸酯、硬脂酸酯、二硬脂酸酯)在化妆品中使用是安全的。关于聚山梨醇酯/山梨醇脂肪酸酯、聚山梨醇酯蜂蜡和聚乙二醇大豆甾醇的数据有限。考虑到密切相关化合物的所有可用信息,可以假设目前在化妆品制剂中使用的这些化合物不会对人类健康构成风险。聚乙二醇蓖麻油和聚乙二醇氢化蓖麻油在静脉注射药品中使用时会引起过敏反应。然而,它们在化妆品中的局部使用被认为是安全的,因为预计它们不会被全身吸收。与所有PEGs和PEG衍生物一样,它们不得应用于受损皮肤。PEGs和PEG衍生物的制造商必须继续努力去除杂质和副产物,如环氧乙烷和1,4 - 二氧六环。总体而言,得出结论,本综述涵盖的PEGs在当前预期使用条件下用于化妆品是安全的。